Unverified50% confidenceDecision RuleExact time
The study stresses that the amount and benefit of synthetic data must be evaluated separately for each disease and each training setting, rather than assuming 'the more the better'.
1
Sources
50%
Confidence
Long-term
Relevance
10/19/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedA reasonable approach is to determine the optimal oversampling level through small-scale experiments for the target disease and model architecture, while monitoring disease-level performance changes.72% similarUnverifiedDuring development, synthetic samples should be used instead of real patient data to validate the tools, and both successful and uncertain results should be checked, comparing reported counts against the generated audit rows.70% similarUnverifiedThe study recommends that evaluating medical models should not rely solely on knowledge-based benchmarks but should also incorporate clinical reasoning assessments.69% similarUnverified医学AI临床验证的性能基准须针对目标人群建立，不能直接沿用公开数据集的评测结果，需通过多中心前瞻性研究证明安全性和有效性68% similarUnverifiedIn a self-administered setting without professional supervision, measurement accuracy, result interpretation, and control of potential health risks are issues that this type of product needs to continuously demonstrate.67% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1065735API
curl https://kongchang.com/api/v1/knowledge/claims/1065735MCP
get_claim(id=1065735)